{
  "doi": "10.1145/3313831.3376649",
  "title": "Isness: Using Multi-Person VR to Design Peak Mystical Type Experiences Comparable to Psychedelics",
  "published": "2020-04-23",
  "proctitle": "CHI '20: Proceedings of the 2020 CHI Conference on Human Factors in Computing Systems",
  "pages": "1-14",
  "year": 2020,
  "badges": [],
  "abstract": "Studies combining psychotherapy with psychedelic drugs (Ds) have demonstrated positive outcomes that are often associated with 'Ds' ability to induce 'mystical-type' experiences (MTEs) i.e., subjective experiences whose characteristics include a sense of connectedness, transcendence, and ineffability. We suggest that both PsiDs and virtual reality can be situated on a broader spectrum of psychedelic technologies. To test this hypothesis, we used concepts, methods, and analysis strategies from D research to design and evaluate 'Isness', a multi-person VR journey where participants experience the collective emergence, fluctuation, and dissipation of their bodies as energetic essences. A study (N=57) analyzing participant responses to a commonly used D experience questionnaire (MEQ30) indicates that Isness participants reported MTEs comparable to those reported in double-blind clinical studies after high doses of psilocybin and LSD. Within a supportive setting and conceptual framework, VR phenomenology can create the conditions for MTEs from which participants derive insight and meaning.",
  "authors": [
    {
      "name": "David R. Glowacki",
      "institution": "University of Bristol & ArtSci International Foundation, Bristol, United Kingdom",
      "img": "/pb-assets/icons/DOs/default-profile-1543932446943.svg",
      "acmid": "99658770489",
      "orcid": "missing"
    },
    {
      "name": "Mark D. Wonnacott",
      "institution": "University of Bristol, Bristol, United Kingdom",
      "img": "/pb-assets/icons/DOs/default-profile-1543932446943.svg",
      "acmid": "99659245439",
      "orcid": "missing"
    },
    {
      "name": "Rachel Freire",
      "institution": "University of Bristol & ArtSci International Foundation, London, United Kingdom",
      "img": "/pb-assets/icons/DOs/default-profile-1543932446943.svg",
      "acmid": "99659143205",
      "orcid": "missing"
    },
    {
      "name": "Becca R. Glowacki",
      "institution": "Goldsmiths College, London, United Kingdom",
      "img": "/pb-assets/icons/DOs/default-profile-1543932446943.svg",
      "acmid": "99659184649",
      "orcid": "missing"
    },
    {
      "name": "Ella M. Gale",
      "institution": "University of Bristol, Bristol, United Kingdom",
      "img": "/pb-assets/icons/DOs/default-profile-1543932446943.svg",
      "acmid": "99659527286",
      "orcid": "missing"
    },
    {
      "name": "James E. Pike",
      "institution": "ArtSci International Foundation, Bristol, United Kingdom",
      "img": "/pb-assets/icons/DOs/default-profile-1543932446943.svg",
      "acmid": "99659528484",
      "orcid": "missing"
    },
    {
      "name": "Tiu de Haan",
      "institution": "ArtSci International Foundation, Bristol, United Kingdom",
      "img": "/pb-assets/icons/DOs/default-profile-1543932446943.svg",
      "acmid": "99659529721",
      "orcid": "missing"
    },
    {
      "name": "Mike Chatziapostolou",
      "institution": "ArtSci International Foundation, Bristol, United Kingdom",
      "img": "/pb-assets/icons/DOs/default-profile-1543932446943.svg",
      "acmid": "99659527423",
      "orcid": "missing"
    },
    {
      "name": "Oussama Metatla",
      "institution": "University of Bristol, Bristol, United Kingdom",
      "img": "/pb-assets/icons/DOs/default-profile-1543932446943.svg",
      "acmid": "81418592476",
      "orcid": "0000-0002-3882-3243"
    }
  ],
  "references": [
    {
      "text": "Barrett, F. S., Johnson, M. W. and Griffiths, R. R. Validation of the revised Mystical Experience Questionnaire in experimental sessions with psilocybin. J Psychopharmacol, 29, 11 (2015), 1182--1190. https://doi.org/10.1177/0269881115609019",
      "doi": ""
    },
    {
      "text": "Barrett, F. S. and Griffiths, R. R. Classic Hallucinogens and Mystical Experiences: Phenomenology and Neural Correlates. Springer, Berlin, Heidelberg, 2017. https://doi.org/10.1007/7854_2017_474",
      "doi": ""
    },
    {
      "text": "Barsuglia, J., Davis, A. K., Palmer, R., Lancelotta, R., Windham-Herman, A.-M., Peterson, K., Polanco, M., Grant, R. and Griffiths, R. R. Intensity of Mystical Experiences Occasioned by 5-MeO-DMT and Comparison With a Prior Psilocybin Study. Front. Psychol., 9, 2459 (2018). https://www.frontiersin.org/article/10.3389/fpsyg.2018.024",
      "doi": ""
    },
    {
      "text": "Bonny, H. L. and Pahnke, W. N. The use of music in psychedelic (LSD) psychotherapy. Journal of Music Therapy, 9, 2 (1972), 64--87. https://doi.org/10.1093/jmt/9.2.64",
      "doi": ""
    },
    {
      "text": "Braun, V. and Clarke, V. Using thematic analysis in psychology. Qualitative Research in Psychology, 3, 2 (2006), 77--101. https://www.tandfonline.com/doi/abs/10.1191/1478088706 qp063oa",
      "doi": ""
    },
    {
      "text": "Carbonaro, T. M., Johnson, M. W., Hurwitz, E. and Griffiths, R. R. Double-blind comparison of the two hallucinogens psilocybin and dextromethorphan: similarities and differences in subjective experiences. Psychopharmacology, 235, 2 (2018), 521--534. https://doi.org/10.1007/s00213-017--4769--4",
      "doi": ""
    },
    {
      "text": "Carhart-Harris, R. L., Erritzoe, D., Williams, T., Stone, J. M., Reed, L. J., Colasanti, A., Tyacke, R. J., Leech, R., Malizia, A. L., Murphy, K., Hobden, P., Evans, J., Feilding, A., Wise, R. G. and Nutt, D. J. Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin. Proc Natl Acad Sci U S A, 109, 6 (2012), 21382143. https://doi.org/10.1073/pnas.1119598109",
      "doi": ""
    },
    {
      "text": "Carhart-Harris, R. L. The entropic brain: a theory of conscious states informed by neuroimaging research with psychedelic drugs (2014), 1--22. https://www.frontiersin.org/articles/10.3389/fnhum.2014.00 020/full",
      "doi": ""
    },
    {
      "text": "Carhart-Harris, R. L., Kaelen, M., Whalley, M. G., Bolstridge, M., Feilding, A. and Nutt, D. J. LSD enhances suggestibility in healthy volunteers. Psychopharmacology, 232, 4 (2015), 785--794. https://doi.org/10.1007/s00213014--3714-z",
      "doi": ""
    },
    {
      "text": "Carhart-Harris, R. L., Muthukumaraswamy, S., Roseman, L., Kaelen, M., Droog, W., Murphy, K., Tagliazucchi, E., Schenberg, E. E., Nest, T., Orban, C., Leech, R., Williams, L. T., Williams, T. M., Bolstridge, M., Sessa, B., McGonigle, J., Sereno, M. I., Nichols, D., Hellyer, P. J., Hobden, P., Evans, J., Singh, K. D., Wise, R. G., Curran, H. V., Feilding, A. and Nutt, D. J. Neural correlates of the LSD experience revealed by multimodal neuroimaging. Proc. Natl. Acad. Sci. U. S. A., 113, 17 (2016), 4853--4858. http://www.pnas.org/lookup/doi/10.1073/pnas.1518377113",
      "doi": ""
    },
    {
      "text": "Carhart-Harris, R. L., Erritzoe, D., Haijen, E., Kaelen, M. and Watts, R. Psychedelics and connectedness. Psychopharmacology, 235, 2 (2017), 547--550. http://link.springer.com/10.1007/s00213-017--4701-y",
      "doi": ""
    },
    {
      "text": "Carhart-Harris, R. L. and Goodwin, G. M. The Therapeutic Potential of Psychedelic Drugs: Past, Present, and Future. Neuropsychopharmacology, 42 (2017), 2105-- 2113. https://doi.org/10.1038/npp.2017.84",
      "doi": ""
    },
    {
      "text": "Carhart-Harris, R. L., Bolstridge, M., Day, C. M. J., Rucker, J., Watts, R., Erritzoe, D. E., Kaelen, M., Giribaldi, B., Bloomfield, M., Pilling, S., Rickard, J. A., Forbes, B., Feilding, A., Taylor, D., Curran, H. V. and Nutt, D. J. Psilocybin with psychological support for treatmentresistant depression: six-month follow-up. Psychopharmacology, 235 (2018), 399--408. https://doi.org/10.1007/s00213-017--4771-x",
      "doi": ""
    },
    {
      "text": "Carhart-Harris, R. L., Roseman, L., Haijen, E., Erritzoe, D., Watts, R., Branchi, I. and Kaelen, M. Psychedelics and the essential importance of context. J Psychopharmacol, 32, 7 (2018), 725--731. https://doi.org/10.1177/0269881118754710",
      "doi": ""
    },
    {
      "text": "Chwelos, N., Blewett, D., Smith, C. and Hoffer, A. Use of d-lysergic acid diethylamide in the treatment of alcoholism. Quarterly journal of studies on alcohol, 20 (1959), 577--590.",
      "doi": ""
    },
    {
      "text": "Denton, J. Can Virtual Reality Replace Psychedelic Drugs? https://psmag.com/social-justice/can-virtual-realityreplace-psychedelic-drugs Pacific Standard (2019).",
      "doi": ""
    },
    {
      "text": "Eastman, P., Friedrichs, M. S., Chodera, J. D., Radmer, R. J., Bruns, C. M., Ku, J. P., Beauchamp, K. A., Lane, T. J., Wang, L.-P., Shukla, D., Tye, T., Houston, M., Stich, T., Klein, C., Shirts, M. R. and Pande, V. S. OpenMM 4: A Reusable, Extensible, Hardware Independent Library for High Performance Molecular Simulation. J. Chem. Theory Comput., 9, 1 (2013), 461--469. http://dx.doi.org/10.1021/ct300857j",
      "doi": ""
    },
    {
      "text": "Garcia-Romeu, A., R Griffiths, R. and W Johnson, M. Psilocybin-occasioned mystical experiences in the treatment of tobacco addiction. Current drug abuse reviews, 7, 3 (2014), 157--164. https://doi.org/10.2174/1874473708666150107121331",
      "doi": ""
    },
    {
      "text": "Glicksohn, J., Berkovich-Ohana, A., Mauro, F. and Ben-Soussan, T. D. Time Perception and the Experience of Time When Immersed in an Altered Sensory Environment. Frontiers in Human Neuroscience, 11, 487 (2017). https://www.frontiersin.org/article/10.3389/fnhum.2017.00",
      "doi": ""
    },
    {
      "text": "Glowacki, B. R., Freire, R., Thomas, L. M., O'Connor, M. B., Jamieson-Binnie, A. and Glowacki, D. R. An open source Etextile VR glove for real-time manipulation of molecular simulations. arXiv:1901.03532 (2019). https://arxiv.org/abs/1901.03532",
      "doi": ""
    },
    {
      "text": "Glowacki, D. R. Perceptions at the nanoscale. Nature Nanotechnology, 14, 5 (2019), 403--403. https://doi.org/10.1038/s41565-019-0452--8",
      "doi": ""
    },
    {
      "text": "Griffiths, R. R., Richards, W. A., McCann, U. and Jesse, R. Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance. Psychopharmacology, 187, 3 (2006), 268--283. http://link.springer.com/10.1007/s00213-0060457--5",
      "doi": ""
    },
    {
      "text": "Griffiths, R. R., Richards, W. A., Johnson, M. W., McCann, U. D. and Jesse, R. Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later. Psychopharmacology, 187, 3 (2008), 268--283. http://journals.sagepub.com/doi/10.1177/026988110809430",
      "doi": ""
    },
    {
      "text": "Griffiths, R. R., Johnson, M. W., Richards, W. A., Richards, B. D., McCann, U. and Jesse, R. Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects. Psychopharmacology, 218, 4 (2011), 649--665. https://doi.org/10.1007/s00213-011--2358-",
      "doi": ""
    },
    {
      "text": "Griffiths, R. R., Johnson, M. W., Carducci, M. A., Umbricht, A., Richards, W. A., Richards, B. D., Cosimano, M. P. and Klinedinst, M. A. Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized doubleblind trial. J Psychopharmacol, 30, 12 (2016), 1181--1197. http://journals.sagepub.com/doi/10.1177/026988111667551",
      "doi": ""
    },
    {
      "text": "Griffiths, R. R., Johnson, M. W., Richards, W. A., Richards, B. D., Jesse, R., MacLean, K. A., Barrett, F. S., Cosimano, M. P. and Klinedinst, M. A. Psilocybinoccasioned mystical-type experience in combination with meditation and other spiritual practices produces enduring positive changes in psychological functioning and in trait measures of prosocial attitudes and behaviors. J Psychopharmacol, 32, 1 (2018), 49--69. https://doi.org/10.1177/0269881117731279",
      "doi": ""
    },
    {
      "text": "Griffiths, R. R., Hurwitz, E. S., Davis, A. K., Johnson, M. W. and Jesse, R. Survey of subjective \"God encounter experiences\": Comparisons among naturally occurring experiences and those occasioned by the classic psychedelics psilocybin, LSD, ayahuasca, or DMT. PLoS ONE, 14, 4 (2019), e0214377. http://dx.plos.org/10.1371/journal.pone.0214377.s003",
      "doi": ""
    },
    {
      "text": "Grof, S., Goodman, L. E., Richards, W. A. and Kurland, A. LSD-assisted psychotherapy in patients with terminal cancer. International pharmacopsychiatry, 8 (1973), 129--144.",
      "doi": ""
    },
    {
      "text": "Grof, S. LSD psychotherapy. Hunter House Pomona, CA, 1980",
      "doi": ""
    },
    {
      "text": "Gullapalli, B. T., Natarajan, A., Angarita, G. A., Malison, R. T., Ganesan, D. and Rahman, T. On-body Sensing of Cocaine Craving, Euphoria and Drug-Seeking Behavior Using Cardiac and Respiratory Signals. Proceedings of the ACM on Interactive, Mobile, Wearable and Ubiquitous Technologies, 3, 2 (2019), 1--31. https://doi.org/10.1145/3328917",
      "doi": "10.1145/3328917"
    },
    {
      "text": "Hart, V., Hawksley, A., Matsumoto, E. A. and Segerman, H. Non-euclidean virtual reality I: explorations of H3 . arXiv:1702.04004 (2017). https://arxiv.org/abs/1702.04004",
      "doi": ""
    },
    {
      "text": "Hart, V., Hawksley, A., Matsumoto, E. A. and Segerman, H. Non-euclidean virtual reality II: explorations of H2 x E. arXiv:1702.04862 (2017). https://arxiv.org/abs/1702.04862",
      "doi": ""
    },
    {
      "text": "Hartogsohn, I. Set and setting, psychedelics and the placebo response: An extra-pharmacological perspective on psychopharmacology. J Psychopharmacol, 30, 12 (2016/12/01 2016), 1259--1267. https://doi.org/10.1177/0269881116677852",
      "doi": ""
    },
    {
      "text": "Hartogsohn, I. Constructing drug effects: A history of set and setting. Drug Science, Policy and Law, 3, 0 (2017), 1--17. https://doi.org/10.1177/2050324516683325",
      "doi": ""
    },
    {
      "text": "Hood, J. R. W., Ghorbani, N., Watson, P. J., Ghramaleki, A. F., Bing, M. N., Davison, H. K., Morris, R. J. and Williamson, W. P. Dimensions of the Mysticism Scale: Confirming the Three-Factor Structure in the United States and Iran. Journal for the Scientific Study of Religion, 40, 4 (2001), 691--705. https://doi.org/10.1111/00218294.00085",
      "doi": ""
    },
    {
      "text": "Huxley, A. The doors of perception and Heaven and hell. Harper & Row, New York, 1963. https://search.library.wisc.edu/catalog/999606461202121",
      "doi": ""
    },
    {
      "text": "James, W. The varieties of religious experience: a study in human nature. New American Library, New York, 1958. https://search.library.wisc.edu/catalog/999774039202121",
      "doi": ""
    },
    {
      "text": "Johnson, M. W., Garcia-Romeu, A., Cosimano, M. P. and Griffiths, R. R. Pilot study of the 5-HT 2AR agonist psilocybin in the treatment of tobacco addiction. J Psychopharmacol, 28, 11 (2014), 983--992. http://journals.sagepub.com/doi/10.1177/026988111454829",
      "doi": ""
    },
    {
      "text": "Johnson, M. W., Garcia-Romeu, A. and Griffiths, R. R. Long-term follow-up of psilocybin-facilitated smoking cessation. The American Journal of Drug and Alcohol Abuse, 43, 1 (2017), 55--60. https://doi.org/10.3109/00952990.2016.1170135",
      "doi": ""
    },
    {
      "text": "Johnson, M. W., Hendricks, P. S., Barrett, F. S. and Griffiths, R. R. Classic psychedelics: An integrative review of epidemiology, therapeutics, mystical experience, and brain network function. Pharmacology and Therapeutics, 197 (2019), 83--102. https://doi.org/10.1016/j.pharmthera.2018.11.010",
      "doi": ""
    },
    {
      "text": "Jones, R. H. Limitations on the Scientific Study of Drug-Enabled Mystical Experiences. Zygon, 54, 3 (2019), 756--792. https://doi.org/10.1111/zygo.12546",
      "doi": ""
    },
    {
      "text": "Kaelen, M., Barrett, F. S., Roseman, L., Lorenz, R., Family, N., Bolstridge, M., Curran, H. V., Feilding, A., Nutt, D. J. and Carhart-Harris, R. L. LSD enhances the emotional response to music. Psychopharmacology, 232, 19 (2015), 3607--3614. https://doi.org/10.1007/s00213-0154014-y",
      "doi": ""
    },
    {
      "text": "Kaptelinin, V. Making the Case for an Existential Perspective in HCI Research on Mortality and Death. Proceedings of the 2016 CHI Conference Extended Abstracts on Human Factors in Computing Systems (2016), 352--364. https://doi.org/10.1145/2851581.2892585",
      "doi": "10.1145/2851581.2892585"
    },
    {
      "text": "Kaptelinin, V. Technology and the Givens of Existence: Toward an Existential Inquiry Framework in HCI Research. Proceedings of the 2018 CHI Conference on Human Factors in Computing Systems (2018), 1--14. https://doi.org/10.1145/3173574.3173844",
      "doi": "10.1145/3173574.3173844"
    },
    {
      "text": "Kellenberger, J. Mysticism and Drugs. Religious Studies, 14, 2 (1978), 175--191.",
      "doi": ""
    },
    {
      "text": "Kitson, A., DiPaola, S. and Riecke, B. E. Lucid Loop: A Virtual Deep Learning Biofeedback System for Lucid Dreaming Practice. 2019 CHI Conference on Human Factors in Computing Systems (2019), LBW1322: 13211326. https://doi.org/10.1145/3290607.3312952",
      "doi": "10.1145/3290607.3312952"
    },
    {
      "text": "Kurland, A., Savage, C., Pahnke, W. N., Grof, S. and Olsson, J. E. LSD in the treatment of alcoholics. Pharmacopsychiatry, 4, 02 (1971), 83--94.",
      "doi": ""
    },
    {
      "text": "Lhooq, M. We tried VR ayahuasca so you don't have to: https://theface.com/life/we-tried-vr-ayahuasca-so-youdont-have-to. The Face (2019).",
      "doi": ""
    },
    {
      "text": "Liechti, M. E., Dolder, P. C. and Schmid, Y. Alterations of consciousness and mystical-type experiences after acute LSD in humans. Psychopharmacology, 234, 9 (2017), 1499--1510. https://doi.org/10.1007/s00213-0164453-0",
      "doi": ""
    },
    {
      "text": "Light, A., Powell, A. and Shklovski, I. Design for Existential Crisis in the Anthropocene Age. Proceedings of the 8th International Conference on Communities and Technologies (2017), 270--279. https://doi.org/10.1145/3083671.3083688",
      "doi": "10.1145/3083671.3083688"
    },
    {
      "text": "Light, A., Shklovski, I. and Powell, A. Design for Existential Crisis. Proceedings of the 2017 CHI Conference Extended Abstracts on Human Factors in Computing Systems (2017), 722--734. https://doi.org/10.1145/3027063.3052760",
      "doi": "10.1145/3027063.3052760"
    },
    {
      "text": "MacLean, K. A., Leoutsakos, J.-M. S., Johnson, M. W. and Griffiths, R. R. Factor Analysis of the Mystical Experience Questionnaire: A Study of Experiences Occasioned by the Hallucinogen Psilocybin. Journal for the Scientific Study of Religion, 51, 4 (2012), 721--737. https://doi.org/10.1111/j.1468--5906.2012.01685.x",
      "doi": ""
    },
    {
      "text": "Madary, M. and Metzinger, T. K. Real Virtuality: A Code of Ethical Conduct. Recommendations for Good Scientific Practice and the Consumers of VR-Technology. Frontiers in Robotics and AI, 3, 3 (2016). https://www.frontiersin.org/article/10.3389/frobt.2016.0000",
      "doi": ""
    },
    {
      "text": "Majic, T., Schmidt, T. T. and Gallinat, J. Peak experiences and the afterglow phenomenon: When and how do therapeutic effects of hallucinogens depend on psychedelic experiences? J Psychopharmacol, 29, 3 (2015), 241--253. https://doi.org/10.1177/0269881114568040",
      "doi": ""
    },
    {
      "text": "Mason, O. J. and Brady, F. The psychotomimetic effects of short-term sensory deprivation. The Journal of nervous and mental disease, 197, 10 (2009), 783--785. https://doi.org/10.1097/NMD.0b013e3181b9760b",
      "doi": ""
    },
    {
      "text": "Mekler, E. D. and Hornb\u00e6k, K. A Framework for the Experience of Meaning in Human-Computer Interaction. Proceedings of the 2019 CHI Conference on Human Factors in Computing Systems (2019), 1--15. http://dl.acm.org/citation.cfm?doid=3290605.3300455",
      "doi": "10.1145/3290605.3300455"
    },
    {
      "text": "Metzner, R., Litwin, G. and Weil, G. The relation of expectation and mood to psilocybin reactions: a questionnaire study. Psychedelic Review, 5 (1965), 3--39.",
      "doi": ""
    },
    {
      "text": "Moroz, M. and Carhart-Harris, R. L. Employing Synergistic Interactions of Virtual Reality and Psychedelics in Neuropsychopharmacology. 2018 IEEE Workshop on Augmented and Virtual Realities for Good (VAR4Good), https://doi.org/10.1109/VAR4GOOD.2018.8576882 (2018).",
      "doi": ""
    },
    {
      "text": "Nardi, B., Tomlinson, B., Patterson, D. J., Chen, J., Pargman, D., Raghavan, B. and Penzenstadler, B. Computing within limits. Communications of the ACM, 61, 10 (2018), 86--93. http://dl.acm.org/citation.cfm?doid=3281635.3183582",
      "doi": "10.1145/3183582"
    },
    {
      "text": "Narupa-Isness https://gitlab.com/intangiblerealities/narupaapplications/isness/tree/legacy. The Intangible Realities Laboratory (2019).",
      "doi": ""
    },
    {
      "text": "Nichols, D. E. Psychedelics. Pharmacological Reviews, 68, 2 (2016), 264--355. http://pharmrev.aspetjournals.org/cgi/doi/10.1124/pr.115.01",
      "doi": ""
    },
    {
      "text": "Nour, M. M., Evans, L., Nutt, D. and Carhart-Harris, R. L. Ego-Dissolution and Psychedelics: Validation of the Ego-Dissolution Inventory (EDI). Frontiers in Human Neuroscience, 10, 269 (2016). https://www.frontiersin.org/article/10.3389/fnhum.2016.00",
      "doi": ""
    },
    {
      "text": "O'Connor, M., Deeks, H. M., Dawn, E., Metatla, O., Roudaut, A., Sutton, M., Thomas, L. M., Glowacki, B. R., Sage, R. and Tew, P. Sampling molecular conformations and dynamics in a multiuser virtual reality framework. Science advances, 4, 6 (2018), eaat2731. https://doi.org/10.1126/sciadv.aat2731",
      "doi": ""
    },
    {
      "text": "O'Connor, M. B., Bennie, S. J., Deeks, H. M., Jamieson-Binnie, A., Jones, A. J., Shannon, R. J., Walters, R., Mitchell, T. J., Mulholland, A. J. and Glowacki, D. R. Interactive molecular dynamics in virtual reality from quantum chemistry to drug binding: An open-source multiperson framework. The Journal of chemical physics, 150, 22 (2019), 220901. https://doi.org/10.1063/1.5092590",
      "doi": ""
    },
    {
      "text": "Pahnke, W. N. and Richards, W. A. Implications of LSD and experimental mysticism. Journal of Religion and Health, 5, 3 (1966), 175--208.",
      "doi": ""
    },
    {
      "text": "Pahnke, W. N., Kurland, A. A., Unger, S., Savage, C. and Grof, S. The experimental use of psychedelic (LSD) psychotherapy. Jama, 212, 11 (1970), 1856--1863.",
      "doi": ""
    },
    {
      "text": "Ross, S., Bossis, A., Guss, J., Agin-Liebes, G., Malone, T., Cohen, B., Mennenga, S. E., Belser, A., Kalliontzi, K., Babb, J., Su, Z., Corby, P. and Schmidt, B. L. Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial. J Psychopharmacol, 30, 12 (2016), 1181--1197. http://journals.sagepub.com/doi/10.1177/026988111667551",
      "doi": ""
    },
    {
      "text": "Rucker, J. J. H., Iliff, J. and Nutt, D. J. Psychiatry and the psychedelic drugs. Past, present, and future. Neuropharmacology, 142 (2018), 200--218. https://doi.org/10.1016/j.neuropharm.2017.12.040",
      "doi": ""
    },
    {
      "text": "Schmid, Y., Hysek, C. M., Simmler, L. D., Crockett, M. J., Quednow, B. B. and Liechti, M. E. Differential effects of MDMA and methylphenidate on social cognition. J Psychopharmacol, 28, 9 (2014), 847--856.",
      "doi": ""
    },
    {
      "text": "Schmidt, T. T. and Berkemeyer, H. The Altered States Database: Psychometric Data of Altered States of Consciousness. Front. Psychol., 9, 1028 (2018), 1--5. https://www.frontiersin.org/article/10.3389/fpsyg.2018.010",
      "doi": ""
    },
    {
      "text": "Stace, W. T. Mysticism and Philosophy. Lippincott, Philadelphia, 1960",
      "doi": ""
    },
    {
      "text": "Studerus, E., Gamma, A., Kometer, M. and Vollenweider, F. X. Prediction of psilocybin response in healthy volunteers. PLoS ONE, 7, 2 (2012), e30800. https://doi.org/10.1371/journal.pone.0030800",
      "doi": ""
    },
    {
      "text": "Suzuki, K., Roseboom, W., Schwartzman, D. J. and Seth, A. K. A deep-dream virtual reality platform for studying altered perceptual phenomenology. Scientific reports, 7, 1 (2017), 15982. https://www.nature.com/articles/s41598-017--16316--2",
      "doi": ""
    },
    {
      "text": "Suzuki, K., Roseboom, W., Schwartzman, D. J. and Seth, A. K. Hallucination Machine: Simulating Altered Perceptual Phenomenology with a Deep-Dream Virtual Reality platform. Artificial Life Conference Proceedings (2018), 111--112. https://doi.org/10.1162/isal_a_00029",
      "doi": ""
    },
    {
      "text": "Thomas, L. M. and Glowacki, D. R. Seeing and feeling in VR: bodily perception in the gaps between layered realities. International Journal of Performance Arts and Digital Media, 14, 2 (2018), 145--168. https://doi.org/10.1080/14794713.2018.1499387",
      "doi": ""
    },
    {
      "text": "Timmermann, C., Roseman, L., Williams, L., Erritzoe, D., Martial, C., Cassol, H., Laureys, S., Nutt, D. and Carhart-Harris, R. DMT Models the Near-Death Experience. Front. Psychol., 9 (2018), 1. https://www.frontiersin.org/article/10.3389/fpsyg.2018.014 24/full",
      "doi": ""
    },
    {
      "text": "Vlisides, P. E., Bel-Bahar, T., Nelson, A., Chilton, K., Smith, E., Janke, E., Tarnal, V., Picton, P., Harris, R. E. and Mashour, G. A. Subanaesthetic ketamine and altered states of consciousness in humans. British Journal of Anaesthesia, 121, 1 (2018/07/01/ 2018), 249--259. http://www.sciencedirect.com/science/article/pii/S0007091",
      "doi": ""
    },
    {
      "text": "Wallace, A. F. C. Cultural Determinants of Response to Hallucinatory Experience. JAMA Psychiatry, 1, 1 (1959), 58--69. https://doi.org/10.1001/archpsyc.1959.03590010074009",
      "doi": ""
    }
  ]
}